Single-entity heparan sulfate glycomimetic clusters for therapeutic applications

Area of Science:

• Biochemistry
• Glycoscience
• Neuroscience

Background:

• Heparan sulfate (HS) is a crucial glycosaminoglycan involved in cell signaling.
• Synthesizing HS oligosaccharides for therapeutic use is complex.
• Polyvalent HS structures on dendritic cores offer potential therapeutic advantages.

Purpose of the Study:

• To synthesize novel single-entity glycomimetic clusters capped with varied HS saccharides.
• To evaluate the ability of these clusters to mimic natural HS saccharides.
• To assess their potential as therapeutic agents for Alzheimer's disease (AD).

Main Methods:

• Synthesis of a targeted library of single-entity glycomimetic clusters.
• Characterization of HS clusters.
• Inhibition assays against the Alzheimer's disease protease BACE-1.

Main Results:

• Successful synthesis of novel single-entity HS clusters.
• Demonstrated mimicry of natural HS saccharides.
• Identification of several HS clusters with low-nanomolar IC50 values against BACE-1.

Conclusions:

• The novel HS clusters are effective drug leads for Alzheimer's disease.
• These compounds offer a new framework for manipulating heparan sulfate-protein interactions.
• This work advances the development of HS-based therapeutics.